Dr. Stanley Rogers is associate clinical professor of surgery, and chief of the Section of Minimally Invasive Surgery in the Division of General Surgery at the University of California, San Francisco. He received a BA in zoology and physiology from the University of Wyoming and an MD from the University of Utah School of Medicine. Dr. Rogers completed his surgical training at UCSF, including his general surgery residency, as well as fellowships in laparoscopic surgery, surgical sonography and GI endoscopy. His research interests are in the areas of liver tumor ablation and GI and bariatric surgery in particular studying minimally invasive surgery .
Dr. Rogers is also director of the Bariatric Surgery Center at UCSF Medical Center, co-director of Videoendoscopic Surgery at San Francisco General Hospital, and a member of the clinical team at the UCSF Helen Diller Family Comprehensive Cancer Center.
In 2012, Dr. Rogers was selected as one of 15 surgeons in the UCSF Department of Surgery to be named as one of America's Top Doctors. This list, prepared by U.S. News & World Report in collaboration with Castle Connolly Medical Ltd., is compiled from a peer nomination process, and recognizes physicians deemed to be among the top 1% in the nation in his or her specialty.
The story of James Dials', a gregarious 62-year-old limousine driver who weighed 400 lbs. and was down on his luck is riveting. “My life was very uncomfortable,” Dials said. “I was a diabetic and I injected insulin. I had high blood pressure, sleep apnea, and high cholesterol. I was on all kinds of medications.” That’s when he discovered the UCSF Bariatric Surgery Program, a Level 1 accredited center for weight-loss surgery by the Bariatric Surgery Center Network of the American College of Surgeons. “James had relatively advanced obesity,” says Stanley Rogers. M.D. , chief of Minimally Invasive Surgery and director of the Bariatric Surgery Center and Liver Tumor Ablation Program at UCSF Medical Center. “And we know that weight loss either with or without surgery can significantly impact those medical problems, and can make these medical problems called co-morbidities go away as weight loss occurs.” “I have all sorts of choices now,” he said. “It’s like a kid getting a new toy on Christmas. That’s how life is to me now. Everything is new in life now. I have more self-esteem and I care more about myself."
A recent study in the New England Journal of Medicine touts a new medical device for the treatment of Gastroesophageal Reflux Disease (GERD) as an alternative to standard therapy, long-term proton-pump inhibitors or Nissen Fundoplication. The new treatment is a surgical procedure in which a small band of magnetic beads is surgically implanted to augment the lower esophageal sphincter, the valve between the esophagus and stomach.
But Stanley J. Rogers, M.D., Associate Professor of Surgery at UCSF, Chief of Minimally Invasive Surgery, and Chief of Bariatric Surgery, expressed concern about its use, telling CBS/KCBS News Healthwatch that the device was essentially untested except for the small study cited above. He cautioned that the beads were a foreign object and where the device was placed could potentially cause serious complications including infection, perforation and abdominal sepsis, leading to ultimate removal. He emphasized that long-term data was needed to demonstrate its safety and effectiveness.
HealthWatch: GERD Necklace Could Be Answer To Acid Reflux (Dr. Rogers Interview)
In its most recent survey, U.S. News named Stanley J. Rogers, M.D. to its list of U.S. News "Top Doctors". Rogers was also named to the prestigious America's Top Doctors (ATD) list, a distinction reserved for the top 1% of physicians in the nation for that specialty. The listings are published online at U.S. News.
UCSF has been accredited by the American College of Surgeons (ACS) as a Level 1 Accredited Bariatric Center (ACS BSCN). The American College of Surgeons Bariatric Surgery Center Network Accreditation Program (ACS BSCN) accredits facilities in the United States that have undergone an independent, voluntary and rigorous peer evaluation in accordance with nationally recognized bariatric surgical standards. This adds to the prestige of the program which previously also earned the Blue Distinction for Bariatric Surgery from Blue Shield of California and was designated a Blue Cross "Center of Expertise Hospital for bariatric surgery.
Stanley Rogers, MD, FACS, Associate Clinical Professor of Surgery and Co-Director of the UCSF Bariatric Surgery Center, and John Cello, MD, Professor of Medicine and Surgery, and Medical Director of Bariatric Surgery Center, recently led a multidisciplinary team in performing the first two of thirty procedures scheduled at the UCSF Medical Center. The investigational procedure, transoral gastroplasty, or "TOGA" for short, is being tested in a clinical trial. UCSF is one of nine U.S. trial sites. Drs. Rogers and Cello are principal investigators on the study.
"Blue Shield's Bariatric Quality Initiative has recognized California surgeons and hospitals for meeting high-quality standards in bariatric surgery. To qualify for this distinction, bariatric surgeons and hospitals had to demonstrate a commitment to quality by meeting a comprehensive set of volume, outcomes, process, and program criteria."